The impact of physician awareness on decision-making preferences in urogynecology
January 16th 2024A recent study revealed that physician awareness of patients' desired level of decision-making significantly enhances satisfaction, highlighting the importance of tailored approaches for women with pelvic floor disorders seeking patient-centered care.
How cardiometabolic factors influence the link between education levels and pregnancy outcomes
January 15th 2024A recent study explored the impact of interventions for cardiometabolic factors in mitigating the influence of lower education levels on various adverse pregnancy outcomes, shedding light on mediators in maternal health.
Disparities in maternal health linked to severe maternal morbidity
January 11th 2024A recent study revealed that Black women, especially those facing extended travel distances for maternity care, are at a heightened risk of severe maternal morbidity, shedding light on needs for equitable maternal care policies in the United States.
Recent findings on low perinatal mortality in prenatally diagnosed vasa previa
January 8th 2024A comprehensive review reveals a minimal 0.5% risk of perinatal death in pregnancies diagnosed with vasa previa prenatally, emphasizing the importance of timely diagnosis and reduced stress for expectant families.
Long-term HPV vaccine efficacy: 10-year study reveals protection in youth
January 4th 2024A decade-long study confirms significant protection against human papillomavirus remains in patients vaccinated up to age 20, reinforcing the World Health Organization's single-dose vaccination recommendation for adolescents.
Maternal folic acid linked to reduced Kawasaki disease risk in infants
January 3rd 2024A study revealed that higher maternal folic acid levels and frequent supplementation during pregnancy can significantly lower the risk of Kawasaki disease in infants, highlighting the potential protective role of folic acid.
Comparison of IV insulin infusion vs CSII in managing intrapartum glycemia
January 2nd 2024A recent study found no significant difference in neonatal hypoglycemia risk between intravenous insulin infusion and continuous subcutaneous insulin infusion for intrapartum glycemic control in pregnant individuals with type 1 diabetes mellitus.